ST人福(600079.SH)：拟向控股股东招商生科定增募资30亿元至35亿元

Group 1 - The core point of the article is that ST Renfu (600079.SH) announced a plan to issue A-shares to a specific group, which is its controlling shareholder,招商生科, through cash subscription [1] - The total amount of funds raised from this issuance is expected to be no less than RMB 300 million and no more than RMB 350 million, which will be used for various projects including innovative drug research and development [1] - The net proceeds after deducting related issuance costs are intended for projects such as the Yichang Renfu project, headquarters research institute project, and the construction of a dual-use health and complex formulation manufacturing base [1]